Stereotactic breast biopsy as an alternative to open excisional biopsy

Michael J. Cross, W. Phil Evans, George N. Peters, J. Harold Cheek, Ronald C. Jones, Patricia Krakos

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Background: Health care cost continues to play a dominant role in our society. Technological advances are expensive, with the possible exception of stereotactic breast biopsy. We must learn other alternatives that give the same diagnostic accuracy at lower cost. The intention of this study was to find other acceptable alternatives to open excisional breast biopsies. Methods: Patients were referred to Baylor University Medical Center betwee between May 1990 and June 1992 for stereotactic breast biopsy of nonpalpable mammographic abnormalities. Before stereotactic biopsy, lesions were categorized into low or high suspicion for malignancy based on screening mammography. Slides were reviewed by a pathologist and the histological diagnosis was compared with mammographic characterization. Benign histology confirming the low-suspicion mammographic abnormality demonstrated mammographic and histologic correlation. Mammographic follow-up was recommended. Results: Two hundred twenty-five women underwent 250 stereotactic breast biopsies. Malignancy was diagnosed in 47 patients; the remaining 203 lesions were benign on pathological examination and are being followed regularly. Seventy-eight percent of the lesions were characterized as low suspicion for malignancy, and 22% were characterized as high suspicion. The average cost saving per lesion using stereotactic biopsy was $1,629. Conclusion: Stereotactic breast biopsy is an acceptable, less expensive alternative to open excisional biopsy for diagnosing nonpalpable mammographic findings.

Original languageEnglish (US)
Pages (from-to)195-200
Number of pages6
JournalAnnals of Surgical Oncology
Volume2
Issue number3
DOIs
StatePublished - May 1995

Fingerprint

Breast
Biopsy
Costs and Cost Analysis
Neoplasms
Mammography
Health Care Costs
Histology

Keywords

  • Core biopsy
  • Nonpalpable masses
  • Stereotactic biopsy

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Stereotactic breast biopsy as an alternative to open excisional biopsy. / Cross, Michael J.; Evans, W. Phil; Peters, George N.; Cheek, J. Harold; Jones, Ronald C.; Krakos, Patricia.

In: Annals of Surgical Oncology, Vol. 2, No. 3, 05.1995, p. 195-200.

Research output: Contribution to journalArticle

Cross, Michael J. ; Evans, W. Phil ; Peters, George N. ; Cheek, J. Harold ; Jones, Ronald C. ; Krakos, Patricia. / Stereotactic breast biopsy as an alternative to open excisional biopsy. In: Annals of Surgical Oncology. 1995 ; Vol. 2, No. 3. pp. 195-200.
@article{d1002c7242d74b28ae435cfa2b4a3dd9,
title = "Stereotactic breast biopsy as an alternative to open excisional biopsy",
abstract = "Background: Health care cost continues to play a dominant role in our society. Technological advances are expensive, with the possible exception of stereotactic breast biopsy. We must learn other alternatives that give the same diagnostic accuracy at lower cost. The intention of this study was to find other acceptable alternatives to open excisional breast biopsies. Methods: Patients were referred to Baylor University Medical Center betwee between May 1990 and June 1992 for stereotactic breast biopsy of nonpalpable mammographic abnormalities. Before stereotactic biopsy, lesions were categorized into low or high suspicion for malignancy based on screening mammography. Slides were reviewed by a pathologist and the histological diagnosis was compared with mammographic characterization. Benign histology confirming the low-suspicion mammographic abnormality demonstrated mammographic and histologic correlation. Mammographic follow-up was recommended. Results: Two hundred twenty-five women underwent 250 stereotactic breast biopsies. Malignancy was diagnosed in 47 patients; the remaining 203 lesions were benign on pathological examination and are being followed regularly. Seventy-eight percent of the lesions were characterized as low suspicion for malignancy, and 22{\%} were characterized as high suspicion. The average cost saving per lesion using stereotactic biopsy was $1,629. Conclusion: Stereotactic breast biopsy is an acceptable, less expensive alternative to open excisional biopsy for diagnosing nonpalpable mammographic findings.",
keywords = "Core biopsy, Nonpalpable masses, Stereotactic biopsy",
author = "Cross, {Michael J.} and Evans, {W. Phil} and Peters, {George N.} and Cheek, {J. Harold} and Jones, {Ronald C.} and Patricia Krakos",
year = "1995",
month = "5",
doi = "10.1007/BF02307023",
language = "English (US)",
volume = "2",
pages = "195--200",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "3",

}

TY - JOUR

T1 - Stereotactic breast biopsy as an alternative to open excisional biopsy

AU - Cross, Michael J.

AU - Evans, W. Phil

AU - Peters, George N.

AU - Cheek, J. Harold

AU - Jones, Ronald C.

AU - Krakos, Patricia

PY - 1995/5

Y1 - 1995/5

N2 - Background: Health care cost continues to play a dominant role in our society. Technological advances are expensive, with the possible exception of stereotactic breast biopsy. We must learn other alternatives that give the same diagnostic accuracy at lower cost. The intention of this study was to find other acceptable alternatives to open excisional breast biopsies. Methods: Patients were referred to Baylor University Medical Center betwee between May 1990 and June 1992 for stereotactic breast biopsy of nonpalpable mammographic abnormalities. Before stereotactic biopsy, lesions were categorized into low or high suspicion for malignancy based on screening mammography. Slides were reviewed by a pathologist and the histological diagnosis was compared with mammographic characterization. Benign histology confirming the low-suspicion mammographic abnormality demonstrated mammographic and histologic correlation. Mammographic follow-up was recommended. Results: Two hundred twenty-five women underwent 250 stereotactic breast biopsies. Malignancy was diagnosed in 47 patients; the remaining 203 lesions were benign on pathological examination and are being followed regularly. Seventy-eight percent of the lesions were characterized as low suspicion for malignancy, and 22% were characterized as high suspicion. The average cost saving per lesion using stereotactic biopsy was $1,629. Conclusion: Stereotactic breast biopsy is an acceptable, less expensive alternative to open excisional biopsy for diagnosing nonpalpable mammographic findings.

AB - Background: Health care cost continues to play a dominant role in our society. Technological advances are expensive, with the possible exception of stereotactic breast biopsy. We must learn other alternatives that give the same diagnostic accuracy at lower cost. The intention of this study was to find other acceptable alternatives to open excisional breast biopsies. Methods: Patients were referred to Baylor University Medical Center betwee between May 1990 and June 1992 for stereotactic breast biopsy of nonpalpable mammographic abnormalities. Before stereotactic biopsy, lesions were categorized into low or high suspicion for malignancy based on screening mammography. Slides were reviewed by a pathologist and the histological diagnosis was compared with mammographic characterization. Benign histology confirming the low-suspicion mammographic abnormality demonstrated mammographic and histologic correlation. Mammographic follow-up was recommended. Results: Two hundred twenty-five women underwent 250 stereotactic breast biopsies. Malignancy was diagnosed in 47 patients; the remaining 203 lesions were benign on pathological examination and are being followed regularly. Seventy-eight percent of the lesions were characterized as low suspicion for malignancy, and 22% were characterized as high suspicion. The average cost saving per lesion using stereotactic biopsy was $1,629. Conclusion: Stereotactic breast biopsy is an acceptable, less expensive alternative to open excisional biopsy for diagnosing nonpalpable mammographic findings.

KW - Core biopsy

KW - Nonpalpable masses

KW - Stereotactic biopsy

UR - http://www.scopus.com/inward/record.url?scp=0029298242&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029298242&partnerID=8YFLogxK

U2 - 10.1007/BF02307023

DO - 10.1007/BF02307023

M3 - Article

C2 - 7641014

AN - SCOPUS:0029298242

VL - 2

SP - 195

EP - 200

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 3

ER -